Home > PJ > Contents

The Pharmaceutical Journal, September 15, 2001

Back issues

Previous  Next

Return to PJ Online Home Page

Leading Article   
   Medical journals get tough
   The NPA looks to the future

News & Features   
   News

   Pharmacists’ place in stroke prevention [more]
   Internal review planned by the NPA [more]

Comment   
   Broad Spectrum: The inevitable needn’t happen! [more]

   Letters to the Editor

Continuing Education   
   Vitamin and mineral supplements
   »(PDF*, 55K), Information sources

Original Papers   
   A partnership between community pharmacists and GPs in the management of ischaemic heart disease: a feasibility study
   »(PDF*, 70K)

Meetings
   
   World Congress of Pharmacy and Pharmaceutical Sciences (FIP) [more]

Onlooker

The Society   
   News
   Official notices
   Obituaries
   
Notice-board
   Branch meetings
   Future events
   Conferences
and more

Products


  * PDF files on PJ Online require Acrobat Reader 4 or later.

Front Cover Picture
This week’s front cover illustration (John Bavosi/SPL) shows how a stroke can be caused by an embolism blocking the cerebral artery. A news feature looks at the way in which community pharmacists in Pembrokeshire are contributing to stroke prevention by getting involved in the monitoring of blood pressure.

Loratadine withdrawal
Schering Plough plans to withdraw prescription packs of loratadine (Clarityn) and hopes that doctors will instead prescribe desloratadine (Neoclarityn), its primary active metabolite.

Sponsored clinical trials
The editors of major medical journals will not publish research conducted under conditions where the sponsor has sole control of the data or is able to withhold publication if the results are unfavourable. Leading article.

NPA internal review
The National Pharmaceutical Association has adopted a five-year plan for improving its service to members. Leading article.

Vitamin supplements
This week’s continuing education article looks at vitamin and mineral supplements.

Pharmacists and IHD
An original paper describes research indicating that community pharmacists can successfully work in partnership with GPs in the secondary prevention of ischaemic heart disease.


©The Pharmaceutical Journal